Arcutis BiotherapeuticsARQT
那斯達克 · USD
28.53
-0.42
(-1.45%)
收盤 12/17 04:59 (UTC+8)
盤後
28.53
28.53
(0.00%)
12/17 04:59 (UTC+8)
Arcutis BiotherapeuticsARQT
28.53
-0.42
(-1.45%)
財務數據
損益表
- 0.05
- 0.38
- 0.14
- 0.50
- 0.31
- 0.45
- 0.71
- 0.66
- 0.82
- 0.99
- 86.62
- 634.28
- -64.51
- 266.47
- -37.75
- 45.04
- 59.45
- -7.73
- 23.78
- 21.74
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 99,219 | 81,504 | 65,846 | 71,360 | 44,755 | 30,858 | 49,569 | 13,526 | 38,109 | 5,190 |
營業成本 | 8,685 | 7,492 | 8,830 | 6,905 | 5,503 | 3,464 | 3,256 | 2,246 | 1,182 | 776 |
營業毛利 | 90,534 | 74,012 | 57,016 | 64,455 | 39,252 | 27,394 | 46,313 | 11,280 | 36,927 | 4,414 |
營業費用 | 82,008 | 88,623 | - | 72,087 | - | - | 77,935 | 72,449 | 73,831 | 71,177 |
研發費用 | 19,604 | 19,453 | 17,543 | 14,480 | 19,501 | 19,298 | 23,141 | 23,775 | 26,236 | 25,219 |
推銷及管理費用 | 62,404 | 69,170 | 64,002 | 57,607 | 58,817 | 58,173 | 54,794 | 48,674 | 47,595 | 45,958 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 8,526 | -14,611 | -24,529 | -7,632 | -39,066 | -50,077 | -31,622 | -61,169 | -36,904 | -66,763 |
其他收入及費用 | 2,035 | 2,096 | 2,730 | 2,718 | 4,182 | 5,229 | 4,044 | 2,672 | 2,786 | 3,121 |
利息費用 | 3,071 | 3,029 | 2,982 | 5,551 | 6,653 | 7,484 | 7,480 | 7,762 | 7,559 | 7,349 |
稅前純益 | 7,490 | -15,544 | -24,781 | -10,465 | -41,537 | -52,332 | -35,058 | -66,259 | -41,677 | -70,991 |
所得稅 | 80 | 342 | 279 | 323 | - | - | 324 | 25 | 3,088 | - |
稅後純益 | 7,410 | -15,886 | -25,060 | -10,788 | -41,537 | -52,332 | -35,382 | -66,284 | -44,765 | -70,991 |
基本每股稅後盈餘(元) | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 |
稀釋每股稅後盈餘(元) | 0.06 | -0.12 | -0.20 | -0.08 | -0.33 | -0.43 | -0.32 | -0.59 | -0.73 | -1.15 |
基本平均股數(千股) | 127623.00 | 126997.00 | 126036.00 | 124918.00 | 124302.00 | 123481.00 | 111048.00 | 92580.00 | 61727.00 | 61430.00 |
稀釋平均股數(千股) | 132885.00 | 126997.00 | 126036.00 | 124918.00 | 124302.00 | 123481.00 | 111048.00 | 92580.00 | 61727.00 | 61430.00 |
還原基本每股稅後盈餘(元) | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 |
還原稀釋每股稅後盈餘(元) | 0.06 | -0.12 | -0.20 | -0.08 | -0.33 | -0.43 | -0.32 | -0.59 | -0.73 | -1.15 |
還原基本平均股數(千股) | 127,623 | 126,997 | 126,036 | 124,918 | 124,302 | 123,481 | 111,048 | 92,580 | 61,727 | 61,430 |
還原稀釋平均股數(千股) | 132,885 | 126,997 | 126,036 | 124,918 | 124,302 | 123,481 | 111,048 | 92,580 | 61,727 | 61,430 |
EBITDA(千元) | 10,572 | -12,800 | -19,526 | -5,057 | -35,144 | -46,885 | -28,945 | -59,584 | -35,263 | -65,080 |